Resources Contact Us Home
Lachance; Nicholas
Pierrefonds, CA
No. of patents:

Patent Number Title Of Patent Date Issued
7429666 Pyridine analogs as C5a antagonists September 30, 2008
The present invention provides novel compounds of Formula I which are antagonists of the C5a receptor. Compounds of the present invention are useful for the treatment of various C5a-mediated diseases and disorders; accordingly the present invention provides a method for the treatment of
6211197 Prostaglandin receptor ligands April 3, 2001
Compounds and methods for treating prostaglandin mediated diseases, and certain pharmaceutical compositions thereof are disclosed. The compounds are represented by formula II:The compounds of the invention are structurally different from NSAIDs and opiates, and are antagonists of the pai

  Recently Added Patents
Compatibility check
System and method for judging success or failure of work of robot
Audio/video program-related hyperlink printer
Sliding-type portable communication device
Stable liquid VEGF antagonist formulations
Selective thermal treatment of medical instrument portions with thermal treatment system instrument holder
  Randomly Featured Patents
Copper material for chemical vapor deposition and process for forming thin film using the same
Impedance measuring device
Processes for producing monoammonium succinate from fermentation broths containing diammonium succinate, monoammonium succinate and/or succinic acid, and conversion of monoammonium succinate t
Apparatus and method of using a fuel gas regulator for a coke oven battery
Stud electrode and process for making same
Lift for raising and lowering an object
Beverage mixing apparatus
Adaptive radar signal processing apparatus
Optical information recording or erasing system
Method for reducing blood pressure